
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Global from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/global/topic/3256/</link>
        <description>Articles tagged with Global from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>AstraZeneca consolidates R&amp;D, moves US commercial roles</title>
          <description>AstraZeneca is cutting 650 jobs in the US, &quot;primarily in R&amp;D,&quot; and consolidating its R&amp;D operations at three &quot;strategic R&amp;D centers&quot; in &quot;bioscience clusters,&quot; academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.</description>
          <link>http://www.mmm-online.com/astrazeneca-consolidates-rd-moves-us-commercial-roles/article/284899/</link>
          <pubDate>Mon, 18 Mar 2013 17:34:04 GMT</pubDate>
          <itunes:summary>AstraZeneca is cutting 650 jobs in the US, &quot;primarily in R&amp;D,&quot; and consolidating its R&amp;D operations at three &quot;strategic R&amp;D centers&quot; in &quot;bioscience clusters,&quot; academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharma&apos;s iPad, emerging-markets strategies to get 2nd look in 2013, agency execs predict</title>
          <description>From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.</description>
          <link>http://www.mmm-online.com/pharmas-ipad-emerging-markets-strategies-to-get-2nd-look-in-2013-agency-execs-predict/article/274051/</link>
          <pubDate>Thu, 27 Dec 2012 14:19:40 GMT</pubDate>
          <itunes:summary>From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Past the patent cliff, pharmas are set for rebound in NMEs, says IMS</title>
          <description>Industry pipelines might not be brimful of blockbusters, but after years of meager output, biopharma firms are poised to tap a cornucopia of innovative treatments as thirty-something New Molecular Entities launch each year through 2016.</description>
          <link>http://www.mmm-online.com/past-the-patent-cliff-pharmas-are-set-for-rebound-in-nmes-says-ims/article/249869/</link>
          <pubDate>Thu, 12 Jul 2012 11:00:00 GMT</pubDate>
          <itunes:summary>Industry pipelines might not be brimful of blockbusters, but after years of meager output, biopharma firms are poised to tap a cornucopia of innovative treatments as thirty-something New Molecular Entities launch each year through 2016.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>McCann renames global health network in bid to broaden beyond drug advertising</title>
          <description>McCann Healthcare Worldwide changed its name to McCann Health, and five of its six US agencies rebranded to align more closely with their parent, the network said today.</description>
          <link>http://www.mmm-online.com/mccann-renames-global-health-network-in-bid-to-broaden-beyond-drug-advertising/article/245686/</link>
          <pubDate>Thu, 14 Jun 2012 14:58:26 GMT</pubDate>
          <itunes:summary>McCann Healthcare Worldwide changed its name to McCann Health, and five of its six US agencies rebranded to align more closely with their parent, the network said today.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pfizer, Crestor tops for global promotional spend in 2011</title>
          <description>Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.</description>
          <link>http://www.mmm-online.com/pfizer-crestor-tops-for-global-promotional-spend-in-2011/article/238922/</link>
          <pubDate>Tue, 01 May 2012 12:00:00 GMT</pubDate>
          <itunes:summary>Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Takeda looks to build vaccines business</title>
          <description>Takeda is getting into vaccines with the launch of a dedicated global division that will make use of Nycomed A/S&apos;s business infrastructure in Europe and emerging markets.</description>
          <link>http://www.mmm-online.com/takeda-looks-to-build-vaccines-business/article/218237/</link>
          <pubDate>Tue, 06 Dec 2011 17:20:21 GMT</pubDate>
          <itunes:summary>Takeda is getting into vaccines with the launch of a dedicated global division that will make use of Nycomed A/S&apos;s business infrastructure in Europe and emerging markets.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: FDA, Ranbaxy, Daiichi Sankyo and ImpactRx</title>
          <description>The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.</description>
          <link>http://www.mmm-online.com/company-news-fda-ranbaxy-daiichi-sankyo-and-impactrx/article/213767/</link>
          <pubDate>Thu, 06 Oct 2011 17:42:19 GMT</pubDate>
          <itunes:summary>The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>UK PR pitch could portend US acquisitions for AstraZeneca</title>
          <description>AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.</description>
          <link>http://www.mmm-online.com/uk-pr-pitch-could-portend-us-acquisitions-for-astrazeneca/article/205305/</link>
          <pubDate>Tue, 14 Jun 2011 19:43:18 GMT</pubDate>
          <itunes:summary>AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Roche-sponsored blog pushes HPV test in UK</title>
          <description>Roche, which is launching an HPV test, is sponsoring a blog by a UK healthcare reporter chronicling the process of getting a pap smear.</description>
          <link>http://www.mmm-online.com/roche-sponsored-blog-pushes-hpv-test-in-uk/article/204734/</link>
          <pubDate>Tue, 07 Jun 2011 18:28:54 GMT</pubDate>
          <itunes:summary>Roche, which is launching an HPV test, is sponsoring a blog by a UK healthcare reporter chronicling the process of getting a pap smear.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Global healthcare pros prefer live reps, survey finds</title>
          <description>For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.</description>
          <link>http://www.mmm-online.com/global-healthcare-pros-prefer-live-reps-survey-finds/article/200726/</link>
          <pubDate>Fri, 15 Apr 2011 13:00:00 GMT</pubDate>
          <itunes:summary>For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  